1. HOME

바이오시밀러

Name Image INN Indications Approved By
NameRemsima®
Rheumatoid arthritis, IBD
INNInfliximab
IndicationsRheumatoid arthritis, inflammatory bowel disease, etc.
Approved By EMA(EU) FDA(US) MFDS(KR)
NameTruxima®
Non-Hodgkin’s lymphoma
INNRituximab
IndicationsNon-Hodgkin’s lymphoma, chronic lymphocytic leukemia, etc.
Approved By EMA(EU) FDA(US) MFDS(KR)
NameHerzuma®
Metastatic breast cancer
INNTrastuzumab
IndicationsMetastatic breast cancer, metastatic gastric cancer, etc.
Approved By EMA(EU) FDA(US) MFDS(KR)
NameRemsima® SC
Rheumatoid arthritis, IBD
INNInfliximab
IndicationsRheumatoid arthritis, inflammatory bowel disease, etc.
Approved By EMA(EU) MFDS(KR)
NameYuflyma®
Rheumatoid arthritis, IBD
INNAdalimumab
IndicationsRheumatoid arthritis, inflammatory bowel disease, etc.
Approved By EMA(EU) FDA(US) MFDS(KR)
NameVegzelma®
Metastatic colorectal cancer
INNBevacizumab
IndicationsMetastatic colorectal cancer, non-small cell lung cancer, etc.
Approved By EMA(EU) FDA(US) MFDS(KR)
NameEydenzelt®
Diabetic macular edema, osteoporosi
INNAflibercept
IndicationsDiabetic macular edema, wet age-related macular degeneration
Approved By MFDS(KR)
NameSteqeyma®
Psoriasis, inflammatory bowel disea
INNUstekinumab
IndicationsPsoriasis, inflammatory bowel disease
Approved By MFDS(KR)

It is not intended for product promotion or sales. For more information, contact your doctor or healthcare professional.

바이오 신약

Name Image INN Indications Approved By
NameZymfentra™
Inflammatory bowel disease
INNInfliximab
IndicationsInflammatory bowel disease
Approved By FDA(US)
NameRegkirona™
COVID-19
INNRegdanvimab
IndicationsCOVID-19
Approved By EMA(EU) MFDS(KR)

It is not intended for product promotion or sales. For more information, contact your doctor or healthcare professional.